In the lung specimen from patients with RA-ILD, numerous CD4 positive T cells are present; thus, it can be speculated that JAKi can suppress the activation of alveolar inflammatory cells by inhibiting multiple cytokines via the JAK–STAT pathway [14, 36]. This evidence concerns the gene SOAT1 and interstitial lung disease.